Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Spring Creek licenses patented oral drug delivery system
June 2010
SHARING OPTIONS:

NEW YORK—Spring Creek Capital Corp., a healthcare solutions company, recently signed a strategic licensing agreement for a patented oral spray drug delivery system via the inner lining of the cheek. The licensing agreement between Spring Creek Capital and McCoy Enterprise LLC/Vectoris Pharma LLC gives Spring Creek the exclusive rights to produce, market, distribute and sell products based on a method of delivering medicine via the mouth, known medically as the buccal mucosa. According to the companies, current market applications for this oral spray technology include delivery of insulin for diabetes, a $10.9 billion market in the United States, and the delivery of calcitonin for osteoporosis, with worldwide sales of more than $1 billion.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.